MOLECULAR PHARMACOLOGY

MOLECULAR PHARMACOLOGY期刊基本信息

MOLECULAR PHARMACOLOGY
  • 简称:MOL PHARMACOL
  • 大类:医学
  • 小类:药学
  • ISSN:0026-895X
  • IF值:3.853
  • 周期:Monthly
  • 是否SCI:SCI/SCIE
  • 是否OA:No
  • 出版地:UNITED STATES
  • 年文章数:120
  • 审稿速度:一般,3-6周
  • 平均录用比例:较难
投稿咨询

官方网站:http://molpharm.aspetjournals.org/

投稿网址:http://submit-molpharm.aspetjournals.org/

PMC链接:http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0026-895X%5BISSN%5D

MOLECULAR PHARMACOLOGY中文简介

分子药理学欢迎报告药物作用或分子水平选择性毒性新信息的手稿供审议。编辑们鼓励投稿阐明分子机制。这些可能包括,例如,受体、信号、途径、酶、通道和转录机制的研究。同时,也鼓励报告开发具有广泛适用性或产生新分子见解的新试剂或新技术的研究。虽然分子药理学试图发表具有很强的生物实验成分的研究,该杂志也欢迎涉及与药物设计或药物作用相关的分子建模的研究。

MOLECULAR PHARMACOLOGY英文简介

Molecular Pharmacology welcomes manuscripts for consideration that report new information on drug action or selective toxicity at the molecular level. The Editors encourage submissions that shed light upon molecular mechanisms. These may include, for example, studies of receptors, signaling, pathways, enzymes,channels, and transcriptional mechanisms. Studies that report the development of novel reagents or technologies that are of broad applicability or yield new molecular insights are also encouraged. While Molecular Pharmacology attempts to publish studies with a strong component of biological experimentation, the journal also welcomes studies that involve molecular modeling relevant to drug design or drug action.

国际期刊推选 论文翻润预审发表!

选择丰富服务快速通过率高一键快速领取私人专属发表方案!

* 请认真填写需求信息,学术顾问24小时内与您取得联系。